Agomelatine Urea | CAS 1366181-82-9 - Request Quote
Agomelatine Urea
| SZ CAT No: | SZ-A044034 |
| CAS No | 1366181-82-9 |
| Mol.F. | C15H17NO2 : CH4N2O |
| Mol.Wt. | 243.3 : 60.1 |
| Inv. Status | In Stock |
| Rel. CAS No | 138112-76-2 (free base) ; 1402352-28-6 (Sulfate salt) ; 1176317-02-4 (HBr salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Agomelatine Urea is chemically N-(2-(7-methoxynaphthalen-1-yl)ethyl)acetamide compound with urea (1:1). Agomelatine Urea is supplied with detailed characterization data compliant with regulatory guideline. Agomelatine Urea can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Agomelatine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1366181-82-9
Purchase 1366181-82-9
Order 1366181-82-9
Enquire 1366181-82-9
price of 1366181-82-9
1366181-82-9 Supplier
1366181-82-9 Manufacturer
1366181-82-9 Exporter
buy high quality Agomelatine Urea
Purchase Agomelatine Urea
Agomelatine Urea suppliers
Agomelatine Urea manufacturers
Agomelatine Urea price
Order Agomelatine Urea
Enquire Agomelatine Urea
Agomelatine Urea cost
Agomelatine Urea Supplier
Agomelatine Urea Distributor
Agomelatine Urea for Method Validation
Agomelatine Reference Standard
Agomelatine Urea for ANDA Filing
Agomelatine Urea for Forced Degradation Studies
Agomelatine Urea Identification Standards
Agomelatine Urea for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.